• OPEN AN ACCOUNT
Indian Indices
Sensex
72,781.89 -251.89
( -0.34%)
Global Indices
Nasdaq
51,707.15 -164.40
(-0.32%)
Dow Jones
7,828.98 0.74
(0.01%)
Hang Seng
67,780.30 2.78
(0.00%)
Nikkei 225
10,649.29 -6.99
(-0.07%)
Forex
USD-INR
95.69 -0.76
(-0.79%)
EUR-INR
107.00 -1.04
(-0.96%)
GBP-INR
126.57 -1.05
(-0.82%)
JPY-INR
0.60 -0.01
(-0.89%)

EQUITY - MARKET SCREENER

Tata Elxsi Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
500408
INE670A01012
488.1333197
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATAELXSI
30.28
21348.44
EPS(TTM)
Face Value()
Div & Yield %
113.15
10
2.19
 

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit
Aug 22,2026
Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.